BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29932143)

  • 1. A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)-The Case of Herbal Medicinal Products Containing St. John's Wort Extracts (SJW).
    Habs M; Binder K; Krauss S; Müller K; Ernst B; Valentini L; Koller M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29932143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. St John's wort for depression: scoping review about perceptions and use by general practitioners in clinical practice.
    Forsdike K; Pirotta M
    J Pharm Pharmacol; 2019 Jan; 71(1):117-128. PubMed ID: 28653745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions.
    Galeotti N
    J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
    Barnes J; Barber N; Wheatley D; Williamson EM
    Planta Med; 2006 Mar; 72(4):378-82. PubMed ID: 16557483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. St. John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit?
    Carpenter DJ
    Altern Med Rev; 2011 Mar; 16(1):17-39. PubMed ID: 21438644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.
    Jungke P; Ostrow G; Li JL; Norton S; Nieber K; Kelber O; Butterweck V
    Psychopharmacology (Berl); 2011 Feb; 213(4):757-72. PubMed ID: 20924750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Less like a drug than a drug': the use of St John's wort among people who self-identify as having depression and/or anxiety symptoms.
    Pirotta M; Willis K; Carter M; Forsdike K; Newton D; Gunn J
    Complement Ther Med; 2014 Oct; 22(5):870-6. PubMed ID: 25440378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?
    Beattie PE; Dawe RS; Traynor NJ; Woods JA; Ferguson J; Ibbotson SH
    Br J Dermatol; 2005 Dec; 153(6):1187-91. PubMed ID: 16307656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages and Disadvantages of Using St. John's Wort as a Treatment for Depression.
    Canenguez Benitez JS; Hernandez TE; Sundararajan R; Sarwar S; Arriaga AJ; Khan AT; Matayoshi A; Quintanilla HA; Kochhar H; Alam M; Mago A; Hans A; Benitez GA
    Cureus; 2022 Sep; 14(9):e29468. PubMed ID: 36299970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
    Solomon D; Adams J; Graves N
    J Affect Disord; 2013 Jun; 148(2-3):228-34. PubMed ID: 23291009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
    Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
    Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
    Mai I; Bauer S; Perloff ES; Johne A; Uehleke B; Frank B; Budde K; Roots I
    Clin Pharmacol Ther; 2004 Oct; 76(4):330-40. PubMed ID: 15470332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of alcohol intake by extract of Hypericum perforatum (St. John's Wort) in two different strains of alcohol-preferring rats.
    Rezvani AH; Overstreet DH; Yang Y; Clark E
    Alcohol Alcohol; 1999; 34(5):699-705. PubMed ID: 10528812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is St. John's wort (Hypericum perforatum) an effective antidepressant?
    Cott JM; Fugh-Berman A
    J Nerv Ment Dis; 1998 Aug; 186(8):500-1. PubMed ID: 9717868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
    Brattström A
    Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of St. John's wort for the treatment of major depression.
    Nangia M; Syed W; Doraiswamy PM
    Public Health Nutr; 2000 Dec; 3(4A):487-94. PubMed ID: 11276296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St. John's Wort. An option for the primary care treatment of depressive patients?
    Gupta RK; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):140-8. PubMed ID: 12904978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.